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Introduction: The placenta responds to adverse environmental conditions, such as 
maternal glucorticoid over-exposure and dietary manipulation, by adapting its 
capacity for substrate transfer to maintain appropriate fetal growth and 
development (Fowden et al. J Neuroendocrinol 20(4):439, 2008). Comparatively 
little is known about placental adaptations to hypoxia and/or oxidative stress. Here, 
we determined the effect of maternal chronic hypoxia on placental morphology and 
established whether maternal treatment with MitoQ protected against hypoxia-
induced alterations in placental structure.  
Methods: Wistar dams were exposed to normoxia (N, 21% O2) or hypoxia (H, 13% 
O2) from days 6-20 of pregnancy +/- MitoQ (500µM in drinking water). On day 20, 
animals were sacrificed and weighed and the placentae were processed for 
stereology.  One placenta per litter per group was used.  This model does not affect 
maternal food intake. 
Results: Neither hypoxic pregnancy or mitoQ treatment affected fetal growth (N: 
3.6±0; H: 3.4±0; HM: 3.6±0; NM: 3.4±0 g). Relative to normoxia, the placental 
absolute volume and the labyrinthine fetal capillary surface area were significantly 
increased in hypoxic pregnancy (Fig. 1 A and B, P<0.05). Maternal MitoQ treatment 
in hypoxic pregnancy additionally increased the maternal blood space surface area 
(Fig. 1C, P<0.05).  
Conclusions: The data show that the placenta adapts to chronic hypoxic pregnancy 
by increasing the fetal capillary surface within the labyrinthine transport zone to 
maintain fetal growth. Maternal mitochondrial targeted antioxidant therapy during 
hypoxic pregnancy improves perfusion on the maternal side of the placenta. 
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